Aventis Pharma’s Q1 net tumbles 21%

04 May 2012 Evaluate

Aventis Pharma’s net profit has declined by 20.75% to Rs 40.1 crore for the first quarter ended March 31, 2012, over the same period previous year. The company reported a net profit of Rs 50.6 crore in the same period of previous year. The profit of the quarter has been impacted due to the amortisation costs relating to the brands and technical know how acquired in 2011 from Universal Medicare and lower interest income as a result of the above investment.

The pharmaceutical company’s net sales rose to Rs 322.5 crore for the first quarter ended March 31, 2012, as compared to Rs 276.3 crore in the corresponding period of last year.

The company's board has recommended a final dividend of Rs 29 per share of a face value of Rs 10 for the year ended December 31, 2012.

Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.